Bausch & Lomb (TSX:BLCO) Beginning Cash Position : C$452 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Beginning Cash Position?

Bausch & Lomb's Beginning Cash Position for the quarter that ended in Mar. 2024 was C$452 Mil.

Bausch & Lomb's quarterly Beginning Cash Position declined from Sep. 2023 (C$530 Mil) to Dec. 2023 (C$483 Mil) and declined from Dec. 2023 (C$483 Mil) to Mar. 2024 (C$452 Mil).

Bausch & Lomb's annual Beginning Cash Position declined from Dec. 2021 (C$305 Mil) to Dec. 2022 (C$240 Mil) but then increased from Dec. 2022 (C$240 Mil) to Dec. 2023 (C$510 Mil).

Bausch & Lomb Beginning Cash Position Historical Data

The historical data trend for Bausch & Lomb's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Beginning Cash Position Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

247.58

245.93

304.64

240.46

509.81

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial												519.95	475.64	530.42	482.98	452.10

Bausch & Lomb Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Bausch & Lomb Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives